Established and Novel Approaches for the Management of Hyposalivation and Xerostomia

Author(s): Andy Wolff, Philip C. Fox, Stephen Porter, Yrjo T. Konttinen

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 34 , 2012

Become EABM
Become Reviewer
Call for Editor


Hyposalivation, often symptomatically manifested as xerostomia (dry mouth sensation) may indicate the presence of altered salivary gland function and places patients at a higher risk for oral complications. Diverse symptoms and consequences have been associated with hyposalivation, such as difficulties with speaking, swallowing and tasting and a significant increase in dental caries and other oral infections. Although hyposalivation may be caused by a variety of conditions (head and neck radiotherapy, Sjögren’s syndrome, medications, etc.), its hallmark symptom, xerostomia, is common to all such disorders, and varies only in intensity. Therefore, treatment is generally non-specific, and similar therapeutic approaches are used in all cases.

In the present paper, available palliative oral care in the form of saliva substitutes, such as mouthwashes or gels, is detailed. Also salivary flow stimulants, such as certain pharmaceutical or gustatory preparations, acupuncture and electrostimulation are reviewed. Finally, other approaches, currently under investigation, such as biological and gene therapies, are discussed. The degree of evidence of the best known methods and their intended use are analyzed.

Keywords: Hyposalivation, xerostomia, dry mouth, mouthwashes, pilocarpine, cevimeline, acupuncture, electrostimulation, salivary gland function, gene therapies.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 02 October, 2012
Page: [5515 - 5521]
Pages: 7
DOI: 10.2174/138161212803307509
Price: $65

Article Metrics

PDF: 53